Cargando…
42. METABOLISM AND CO-MORBIDITIES IN PSYCHOTIC DISORDERS
Overall Abstract: Schizophrenia is associated with a reduced life expectancy of 15–20 years due to a high prevalence of cardiovascular disease and metabolic syndrome. Unhealthy lifestyles and pharmacological side effects have been suggested to be a major cause of excess mortality rates in patients w...
Autor principal: | Oresic, Matej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888753/ http://dx.doi.org/10.1093/schbul/sby014.173 |
Ejemplares similares
-
42.3 METABOLOMICS APPROACHES TO STUDY METABOLIC CO-MORBIDITIES IN PSYCHOTIC DISORDERS
por: Hyötyläinen, Tuulia, et al.
Publicado: (2018) -
Obesity and psychotic disorders: uncovering common mechanisms through metabolomics
por: Orešič, Matej
Publicado: (2012) -
Molecular lipids in prediction of psychosis and the associated cardiometabolic co-morbidities
por: Oresic, M.
Publicado: (2021) -
Psychotic disorders in migrant population
por: Felgueiras, P., et al.
Publicado: (2021) -
T159. ASSOCIATION BETWEEN VITAMIN D INSUFFICIENCY AND METABOLIC SYNDROME IN PATIENTS WITH PSYCHOTIC DISORDERS
por: Kim, Sung-Wan, et al.
Publicado: (2018)